Hi Wayne,
As I mentioned in my previous post, I don't think the Peptidream slide was added to the new Investor Presentation without some serious strategic thought and hint of what the company objectives are moving forward. All eyes will be on validation of the company's new Endosomal Escape Technology first then the Macrocycle Technology.
Here is just one passage taken from this excellent review: Bringing Macrocycles Full Circle ...
“We need to have a very focused effort on really understanding what exactly are the mechanisms of endocytic vesicle trafficking,” according to Verdine. “This is going to require that the federal funding agencies stop thinking of endosomal biology as a backwater, just as 25–30 years ago RNA biology was a backwater. We have to stay ahead of the curve and say endosomal biology is the next big thing in biology.”
Regards,
Tony
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 40248 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |